Form 4: Lexeo Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4
Jenny Robertson, Chief Legal Officer of Lexeo Therapeutics, sold 2,101 shares of common stock on February 19, 2025, to cover tax obligations related to the release of restricted stock units.
Summary
- On February 19, 2025, Jenny Robertson, the Chief Legal Officer of Lexeo Therapeutics, sold 2,101 shares of the company's common stock.
- The sale was executed at a price of $4.413 per share.
- This transaction was conducted to cover tax obligations arising from the release of restricted stock units (RSUs).
- Following the transaction, Robertson beneficially owns 57,899 shares, which includes 54,062 RSUs.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) and doesn't indicate any significant positive or negative sentiment.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date of the stock sale transaction. |
| 02/21/2025 | Date of signature on the Form 4 filing. |
Keywords
Lexeo Therapeutics, Jenny Robertson, Chief Legal Officer, stock sale, Form 4, restricted stock units, tax obligations, LXEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.